Meeting report of the 7th Heidelberg Myeloma Workshop: today and tomorrow.

Baertsch, M A; Lutz, R; Raab, M S; Weinhold, N; Goldschmidt, H

Baertsch, M A; Lutz, R; Raab, M S; Weinhold, N; Goldschmidt, H.

Afiliação

Baertsch MA; Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany. marc-andrea.baertsch@med.uni-heidelberg.de.
Lutz R; Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Raab MS; Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Weinhold N; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.
Goldschmidt H; Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.

J Cancer Res Clin Oncol ; 145(10): 2445-2455, 2019 Oct.

Article em En | MEDLINE | ID: mdl-31407112

Assuntos

Mieloma Múltiplo/diagnóstico; Mieloma Múltiplo/terapia; Gerenciamento Clínico; Humanos; Mieloma Múltiplo/etiologia; Mieloma Múltiplo/mortalidade

Palavras-chave

Immunotherapy; Minimal residual disease; Multiple myeloma; Single-cell sequencing

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google